Jim Cramer's advice on Abbott Labs stock after a nearly $500 million baby formula verdict

Health Care Industry News

Jim Cramer's advice on Abbott Labs stock after a nearly $500 million baby formula verdict
Abbott LaboratoriesStarbucks CorpAmazon.Com Inc
  • 📰 CNBC
  • ⏱ Reading Time:
  • 25 sec. here
  • 17 min. at publisher
  • 📊 Quality Score:
  • News: 65%
  • Publisher: 72%

The Investing Club holds its 'Morning Meeting' every weekday at 10:20 a.m. ET.

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Monday's key moments. Wall Street was lower after Friday's rebound in a wild week that featured rotations in and out of tech. It's a busy week ahead with a Fed meeting, 14 earnings from Club names , and the government's jobs report on the docket. Among this week's earnings are Microsoft , Meta Platforms and Apple and Amazon .

Following a nearly $500 million verdict for the plaintiffs in a trial over allegations about the dangers of formula for premature babies, Jim called Abbott Laboratories a disaster, but the "disaster is not yet priced in" to the stock. The company has lost some $30 billion in market cap since a smaller, similar verdict went against a competitor's brand. Jim does not think a verdict of this size against Abbott, which he criticized as "insane," will stand.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

Abbott Laboratories Starbucks Corp Amazon.Com Inc Meta Platforms Inc Microsoft Corp Apple Inc Breaking News: Markets Markets Investment Strategy Jim Cramer Morning Meeting Recaps Breaking News: Technology Technology Pharmaceuticals Business News

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

10 things to watch in the stock market Monday including a defense of Abbott Labs10 things to watch in the stock market Monday including a defense of Abbott LabsWall Street is looking to kick off the third quarter on a higher note.
Read more »

Here's why Abbott Labs stock is getting dinged after a strong earnings beatHere's why Abbott Labs stock is getting dinged after a strong earnings beatShares are even more attractive when we consider the company's pipeline.
Read more »

Jim Cramer's top 10 things to watch in the stock market ThursdayJim Cramer's top 10 things to watch in the stock market ThursdayNasdaq futures rose Thursday after the tech-heavy Nasdaq Composite posted its worst day since 2022.
Read more »

Jim Cramer's top 10 things to watch in the stock market TuesdayJim Cramer's top 10 things to watch in the stock market TuesdayU.S. stock futures rose after better-than-expected earnings and retail sales data.
Read more »

Jim Cramer's top 10 things to watch in the stock market WednesdayJim Cramer's top 10 things to watch in the stock market WednesdayWall Street is headed for a lower open Wednesday, a day after the S&P 500 and Dow closed at record highs.
Read more »

Jim Cramer's top 10 things to watch in the stock market ThursdayJim Cramer's top 10 things to watch in the stock market ThursdayThe S&P 500 and Nasdaq, both on seven-session winning streaks, were looking lower after more records.
Read more »



Render Time: 2025-02-16 06:44:14